JPMORGAN CHASE & CO

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol
KROS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
113,803 shares
Security Ownership %
0.2%
Shares, Excluding Options vs Price
Value, Excluding Options

JPMORGAN CHASE & CO. ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

05 May 2025 - JPMORGAN CHASE & CO. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 113,803 shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS). This represents 0.2% ownership of the company. In their previous filing dated 02 May 2025, JPMORGAN CHASE & CO had reported owning 2,587,146 shares, indicating a decrease of +96%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.